Loading...
XNYS
RZC
Market cap14bUSD
Jul 09, Last price  
25.37USD
1D
0.12%
1Q
0.20%
Name

Reinsurance Group of America Inc

Chart & Performance

D1W1MN
XNYS:RZC chart

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Reinsurance Group of America, Inc. functions as a holding company, concentrating on both conventional and cutting-edge life and health reinsurance offerings. Its operations are structured across five primary segments: the U.S. and Latin America, Canada, Europe, the Middle East and Africa (EMEA), Asia Pacific, and a distinct Corporate and Other division. The U.S. and Latin America segment is responsible for marketing individual and group life and health reinsurance to clients within its region, employing various agreement types such as yearly renewable term, coinsurance, and modified coinsurance. In Canada, the company's focus is on individual life reinsurance, supplemented by a lesser extent of creditor, group life and health, critical illness, and disability reinsurance, generally through yearly renewable term and coinsurance contracts. The EMEA segment provides individual and group life and health products, including critical illness coverage—which offers a benefit upon the diagnosis of a specified illness—and underwritten annuities, typically facilitated via yearly renewable term and coinsurance agreements. The Asia Pacific segment covers individual and group life and health reinsurance, critical illness coverage, disability, and superannuation, predominantly structured with yearly renewable term and coinsurance agreements. Finally, the Corporate and Other segment encompasses investment income from unallocated assets, investment-related gains and losses, and service fee revenues. Founded in 1973, the company's corporate headquarters are situated in Chesterfield, Missouri.
IPO date
May 03, 1993
Employees
3,800
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT